NCT03570970View on ClinicalTrials.gov

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 14, 2016

Primary Completion Date

June 2, 2016

Study Completion Date

June 2, 2016

Conditions
Healthy Subject
Interventions
DRUG

Banapenem

Banapenem to be used anti-infection

All Listed Sponsors
lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT03570970 - Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects | Biotech Hunter | Biotech Hunter